Marcelo H Losso
Overview
Explore the profile of Marcelo H Losso including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
41
Citations
1442
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Beigel J, Manosuthi W, Beeler J, Bao Y, Hoppers M, Ruxrungtham K, et al.
Clin Infect Dis
. 2019 Sep;
70(11):2317-2324.
PMID: 31541242
Background: Duration of viral shedding is a determinant of infectivity and transmissibility, but few data exist about oseltamivir's ability to alter viral shedding. Methods: From January 2012 through October 2017,...
12.
Ekenberg C, Tang M, Zucco A, Murray D, Macpherson C, Hu X, et al.
J Infect Dis
. 2019 Jun;
220(8):1325-1334.
PMID: 31219150
The impact of variation in host genetics on replication of human immunodeficiency virus type 1 (HIV-1) in demographically diverse populations remains uncertain. In the current study, we performed a genome-wide...
13.
Aboud M, Kaplan R, Lombaard J, Zhang F, Hidalgo J, Mamedova E, et al.
Lancet Infect Dis
. 2019 Feb;
19(3):253-264.
PMID: 30732940
Background: Doubts exist regarding optimal second-line treatment options for HIV-1-infected patients in resource-limited settings. We assessed safety and efficacy of dolutegravir compared with ritonavir-boosted lopinavir, plus two nucleoside reverse transcriptase...
14.
Caro-Vega Y, Schultze A, W Efsen A, Post F, Panteleev A, Skrahin A, et al.
BMC Infect Dis
. 2018 Apr;
18(1):191.
PMID: 29685113
Background: Efavirenz-based antiretroviral therapy (ART) regimens are preferred for treatment of adult HIV-positive patients co-infected with tuberculosis (HIV/TB). Few studies have compared outcomes among HIV/TB patients treated with efavirenz or...
15.
Dwyer D, Lynfield R, Losso M, Davey R, Cozzi-Lepri A, Wentworth D, et al.
Open Forum Infect Dis
. 2018 Jan;
4(4):ofx212.
PMID: 29308401
Background: Outcome data from prospective follow-up studies comparing infections with different influenza virus types/subtypes are limited. Methods: Demographic, clinical characteristics and follow-up outcomes for adults with laboratory-confirmed influenza A(H1N1)pdm09, A(H3N2),...
16.
Kundro M, Viloria G, Toibaro J, Losso M
Medicina (B Aires)
. 2017 Oct;
77(5):365-369.
PMID: 29044011
Cardiovascular risk is increased in HIV-infected patients and has become a leading cause of morbi-mortality in this population. The purpose of this study is to compare HIV-infected patients on antiretroviral...
17.
Beigel J, Bao Y, Beeler J, Manosuthi W, Slandzicki A, Dar S, et al.
Lancet Infect Dis
. 2017 Sep;
17(12):1255-1265.
PMID: 28958678
Background: Influenza continues to have a substantial socioeconomic and health impact despite a long established vaccination programme and approved antivirals. Preclinical data suggest that combining antivirals might be more effective...
18.
Kundro M, Terwel S, Toibaro J, Viloria G, Losso M
Medicina (B Aires)
. 2016 Oct;
76(5):273-278.
PMID: 27723614
Recent findings from the START Trial provided evidence that early initiation of antiretroviral treatment should be implemented as the global standard of care. However, a large proportion of patients are...
19.
Podlekareva D, W Efsen A, Schultze A, Post F, Skrahina A, Panteleev A, et al.
Lancet HIV
. 2016 Mar;
3(3):e120-31.
PMID: 26939735
Background: Management of tuberculosis in patients with HIV in eastern Europe is complicated by the high prevalence of multidrug-resistant tuberculosis, low rates of drug susceptibility testing, and poor access to...
20.
W Efsen A, Schultze A, Post F, Panteleev A, Furrer H, Miller R, et al.
PLoS One
. 2015 Dec;
10(12):e0145380.
PMID: 26716686
Objectives: Rates of TB/HIV coinfection and multi-drug resistant (MDR)-TB are increasing in Eastern Europe (EE). We aimed to study clinical characteristics, factors associated with MDR-TB and predicted activity of empiric...